Shared care guidelines
Loading…
Please refer to the introduction for an overview of shared care and shared care guidelines and to find the relevant templates and request forms.
April 2022 - APC Approved list of guideline review date extensions (to 3 years from date approved)
-
Drug Monitoring in Adults in Primary Care
Brain and mental health
Cancer, Palliative Care, Pain and Older People
Cardiovascular and Lipids
Dermatology, MSK and Rheumatology
Endocrine and Diabetes
Gastroenterology
Laboratory investigations and Infections
Renal, Urology and Mens Health
Respiratory and Smoking
Women's and Sexual Health
-
Finerenone in patients with CKD and type 2 diabetes
Endocrine and Diabetes
-
Freestyle Libre - Protocol for Adults (APC Approved)
Endocrine and Diabetes
-
Freestyle Libre - Protocol for Children (APC Approved)
Endocrine and Diabetes
-
GLP1 Agonist (APC Approved)
Endocrine and Diabetes
This guidance has been produced following an AMBER-G classification status of liraglutide, lixisenatide, dulaglutide and semaglutide by the Barnsley Area Prescribing Committee. This guideline was ratified by the Area Prescribing Committee on 12th February 2020.
-
Insulin Aspart (Fiasp)
Endocrine and Diabetes
-
Liothyronine (T3) Shared Care Guideline
Endocrine and Diabetes
-
Toujeo
Endocrine and Diabetes
-
Tresiba
Endocrine and Diabetes
Did you find this page helpful?